237 related articles for article (PubMed ID: 35246682)
1. Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report.
Molina-Rios S; Rojas-Martinez R; Estévez-Ramirez GM; Medina YF
Mod Rheumatol Case Rep; 2023 Jan; 7(1):43-46. PubMed ID: 35246682
[TBL] [Abstract][Full Text] [Related]
2. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination.
Moriyama M; Noda K; Ito H; Matsushita T; Kurosaka D
Mod Rheumatol Case Rep; 2023 Dec; 8(1):63-68. PubMed ID: 37348045
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus.
Giannopoulou N; Gupta L; Andreoli L; Lini D; ; Nikiphorou E; Aggarwal R; Agarwal V; Parodis I
Autoimmun Rev; 2023 Apr; 22(4):103292. PubMed ID: 36740090
[TBL] [Abstract][Full Text] [Related]
5. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
Zavala-Flores E; Salcedo-Matienzo J; Quiroz-Alva A; Berrocal-Kasay A
Clin Rheumatol; 2022 May; 41(5):1349-1357. PubMed ID: 34782941
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyopathy following COVID-19 vaccination in a patient with systemic lupus erythematosus.
Bhullar AK; Chew ZC; Ong PS; Khor CG; Mohd Amin NH
Mod Rheumatol Case Rep; 2023 Jan; 7(1):87-91. PubMed ID: 36069645
[TBL] [Abstract][Full Text] [Related]
7. Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey.
Tang Q; Li F; Tian J; Kang J; He J
Clin Exp Med; 2023 Jun; 23(2):457-463. PubMed ID: 35612692
[TBL] [Abstract][Full Text] [Related]
8. Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus: a case-based review.
Garcia-Diaz J; Escudero-Salamanca M; Alvarez-Santana R; Espinola-Zavaleta N
Future Cardiol; 2021 Sep; 17(6):985-990. PubMed ID: 33140653
[TBL] [Abstract][Full Text] [Related]
9. Catastrophic Anti-Phospholipid Syndrome in Systemic Lupus Erythematosus: A Tsunami in the Ocean.
Dorji T; Hegde A; Asturkar V; Yangzom S; Bhanu K
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443434
[TBL] [Abstract][Full Text] [Related]
10. Lupus, vaccinations and COVID-19: What we know now.
Mason A; Anver H; Lwin M; Holroyd C; Faust SN; Edwards CJ
Lupus; 2021 Sep; 30(10):1541-1552. PubMed ID: 34134555
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series.
Cahuapaza-Gutierrez NL
Lupus; 2024 Apr; 33(4):375-386. PubMed ID: 38315894
[TBL] [Abstract][Full Text] [Related]
12. [Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future].
Nasonov EL; Reshetnyak TM; Solovyev SK; Popkova TV
Ter Arkh; 2023 Jul; 95(5):365-374. PubMed ID: 38158987
[TBL] [Abstract][Full Text] [Related]
13. Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.
Yoshida T; Tsuji H; Onishi A; Takase Y; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Tanaka M; Yoshifuji H; Morinobu A
Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35961691
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of acute aortic dissection in a patient with SLE and prior antiphospholipid syndrome on therapy for over 30 years: a case report.
Yamamoto T; Endo D; Shimada A; Matsushita S; Asai T; Amano A
BMC Cardiovasc Disord; 2022 May; 22(1):216. PubMed ID: 35562652
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.
Nakahara Y; Yamane M; Sunada M; Aoyama Y
J Dermatol; 2023 Feb; 50(2):162-165. PubMed ID: 36578130
[TBL] [Abstract][Full Text] [Related]
16. Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus.
Carvalho JF; Silva FF; Shoenfeld Y
Lupus; 2021 Jan; 30(1):155-157. PubMed ID: 33081592
[TBL] [Abstract][Full Text] [Related]
17. A novel presentation of childhood systemic lupus erythematosus in a 6-year-old child.
Wurster A; Bauler L; Howing C; McGlinchey Ford M
Lupus; 2022 Sep; 31(10):1276-1279. PubMed ID: 35801959
[TBL] [Abstract][Full Text] [Related]
18. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
[TBL] [Abstract][Full Text] [Related]
19. Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico.
González-Meléndez A; Báez-Negrón L; Ríos-Rivera R; Franco-O'Connell AS; Nieves-Plaza M; Vilá LM
Lupus; 2023 Apr; 32(4):571-579. PubMed ID: 36639887
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
